Citadel Advisors’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.17M Sell
103,244
-4,318
-4% -$49K ﹤0.01% 3150
2025
Q1
$715K Buy
107,562
+14,982
+16% +$99.6K ﹤0.01% 3638
2024
Q4
$1.02M Buy
92,580
+85,630
+1,232% +$944K ﹤0.01% 3230
2024
Q3
$85.4K Buy
+6,950
New +$85.4K ﹤0.01% 4984
2024
Q2
Hold
0
6772
2024
Q1
Sell
-15,577
Closed -$81.9K 6801
2023
Q4
$81.9K Sell
15,577
-60,543
-80% -$318K ﹤0.01% 4946
2023
Q3
$300K Sell
76,120
-96,178
-56% -$379K ﹤0.01% 4255
2023
Q2
$1.83M Sell
172,298
-52,167
-23% -$555K ﹤0.01% 2493
2023
Q1
$1.87M Sell
224,465
-85,041
-27% -$708K ﹤0.01% 2602
2022
Q4
$2.86M Buy
309,506
+37,725
+14% +$348K ﹤0.01% 2266
2022
Q3
$3.49M Buy
271,781
+146,544
+117% +$1.88M ﹤0.01% 2194
2022
Q2
$1.65M Sell
125,237
-3,295
-3% -$43.5K ﹤0.01% 2922
2022
Q1
$2.71M Buy
128,532
+120,110
+1,426% +$2.53M ﹤0.01% 2681
2021
Q4
$202K Sell
8,422
-20,945
-71% -$502K ﹤0.01% 5474
2021
Q3
$747K Sell
29,367
-29,765
-50% -$757K ﹤0.01% 4096
2021
Q2
$1.99M Buy
59,132
+26,802
+83% +$902K ﹤0.01% 3225
2021
Q1
$1.26M Buy
+32,330
New +$1.26M ﹤0.01% 3673
2020
Q4
Hold
0
5566
2020
Q3
Hold
0
5236
2020
Q2
Sell
-18,865
Closed -$432K 5265
2020
Q1
$432K Buy
18,865
+8,400
+80% +$192K ﹤0.01% 3513
2019
Q4
$296K Buy
+10,465
New +$296K ﹤0.01% 3884
2019
Q3
Sell
-99,818
Closed -$2.91M 5113
2019
Q2
$2.91M Buy
+99,818
New +$2.91M ﹤0.01% 2110